Whalen Wealth Management Inc. Purchases New Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Whalen Wealth Management Inc. acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 10,887 shares of the company’s stock, valued at approximately $253,000.

Other large investors also recently bought and sold shares of the company. Wellington Management Group LLP lifted its position in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after acquiring an additional 1,328,326 shares in the last quarter. FMR LLC lifted its holdings in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after purchasing an additional 4,304,896 shares in the last quarter. Westfield Capital Management Co. LP lifted its holdings in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares in the last quarter. State Street Corp boosted its stake in Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after purchasing an additional 83,395 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its position in shares of Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after buying an additional 404,811 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Trading Down 0.5 %

Shares of Option Care Health stock opened at $29.31 on Thursday. The stock has a 50 day moving average of $24.10 and a 200 day moving average of $27.78. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market capitalization of $4.99 billion, a price-to-earnings ratio of 24.63, a PEG ratio of 2.12 and a beta of 1.31. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on OPCH shares. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price target for the stock from $26.00 to $35.00 in a research report on Thursday. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and a consensus price target of $31.14.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.